Jenny Westin

Medicine & Life Sciences

1. Dyskinesias 100%
2. Corpus Striatum 49%
3. Basal Ganglia 30%
4. Oxidopamine 29%
5. Levodopa 29%
6. Cell Plasticity 28%
7. Dopamine D1 Receptors 26%
8. Parkinson Disease 26%
9. Mitogen-Activated Protein Kinase 3 24%
10. Alanine 24%
11. Mitogen-Activated Protein Kinase 1 24%
12. preproenkephalin 23%
13. Blood-Brain Barrier 22%
14. Entopeduncular Nucleus 22%
15. Gene Expression Profiling 22%
16. Gene Expression 21%
17. Permeability 20%
18. Pars Reticulata 19%
19. Dopamine 16%
20. Bromodeoxyuridine 15%
21. Phosphorylation 14%
22. rat endothelial barrier antigen 13%
23. Bromocriptine 13%
24. Denervation 11%
25. Neuronal Plasticity 10%
26. Messenger RNA 9%
27. Blood Vessels 9%
28. Injections 9%
29. Down-Regulation 9%
30. Dynorphins 9%
31. Up-Regulation 8%
32. Nestin 8%
33. Globus Pallidus 8%
34. Antiparkinson Agents 7%
35. Serum Albumin 7%
36. SCH 23390 6%
37. Thymidine 6%
38. Adenosine Triphosphate 6%
39. Opioid Analgesics 6%
40. Phosphotransferases 6%
41. RNA Precursors 6%
42. Genes 6%
43. Neurons 5%
44. Parkinsonian Disorders 5%
45. Theoretical Models 5%
46. Therapeutics 5%
47. GABAergic Neurons 5%
48. Kinetics 5%
49. Proteins 5%
50. Duration of Therapy 5%